Guided Therapeutics (GTHP) EBT Margin (2010 - 2025)
Guided Therapeutics' (GTHP) quarterly EBT Margin came in at 206.44% in Q4 2025, up 6499356.0% year-over-year from N/an in Q4 2024, and up 83.31% quarter-over-quarter from 1236.67% in Q3 2025.
Powered by 
Analysis
Guided Therapeutics (GTHP) EBT Margin (2010 - 2025) Analysis & Trends
Guided Therapeutics has disclosed EBT Margin across 16 years of filings, most recently posting 206.44% for Q4 2025.
- In Q4 2025, EBT Margin rose 6499356.0% year-over-year to 206.44%; the TTM figure through Jun 2026 stood at 471.54% (up 168439.0% YoY), while the FY2025 annual figure was 416.69%, up 3411188.0% from the prior year.
- EBT Margin came in at 206.44% for Q4 2025 at Guided Therapeutics, up from 1236.67% in the prior quarter.
- In the past five years, EBT Margin ranged from a high of 357.89% in Q3 2021 to a low of 65200.0% in Q4 2024.
- Average EBT Margin over 5 years is 14300.47%, with a median of 3744.32% recorded in 2023.
- Year-over-year, EBT Margin sank 6399375 bps in 2024 and jumped 6499356 bps in 2025.
- Over 5 years, EBT Margin stood at 740.0% in 2021, then plunged by 4864 bps to 36733.33% in 2022, then soared by 97 bps to 1206.25% in 2023, then sank by 5305 bps to 65200.0% in 2024, then jumped by 100 bps to 206.44% in 2025.
- Per Business Quant data, the three most recent EBT Margin figures were 206.44% in Q4 2025, 1236.67% in Q3 2025, and 693.16% in Q2 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 181.16 Bn | 175.56 Bn | 7.27 Bn | 12.10% |
| 2 | Intuitive Surgical | 127.08 Bn | 121.86 Bn | 1.96 Bn | 36.46% |
| 3 | Medtronic | 117.20 Bn | 108.39 Bn | 6.34 Bn | 18.13% |
| 4 | Stryker | 105.03 Bn | 101.55 Bn | 4.50 Bn | 23.74% |
| 5 | Boston Scientific | 64.54 Bn | 64.00 Bn | 3.85 Bn | 19.48% |
| 6 | Edwards Lifesciences | 49.82 Bn | 45.57 Bn | 1.35 Bn | 29.86% |
| 7 | Alcon | 33.15 Bn | 31.69 Bn | 1.68 Bn | -1.65% |
| 8 | Dexcom | 32.02 Bn | 30.07 Bn | 830.00 Mn | 24.27% |
| 9 | Steris | 20.71 Bn | 20.23 Bn | 684.20 Mn | 18.32% |
| 10 | Guided Therapeutics | 19.31 Mn | 19.30 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -206.44% |
| Sep 30, 2025 | -1,236.67% |
| Jun 30, 2025 | -693.16% |
| Dec 31, 2024 | -65,200.00% |
| Mar 31, 2024 | -6,700.00% |
| Dec 31, 2023 | -1,206.25% |
| Jun 30, 2023 | -3,538.64% |
| Mar 31, 2023 | -3,950.00% |
| Sep 30, 2022 | -36,733.33% |
| Jun 30, 2022 | -18,520.00% |
| Mar 31, 2022 | -10,140.00% |
| Dec 31, 2021 | -740.00% |
| Sep 30, 2021 | 357.89% |
| Jun 30, 2021 | -51,700.00% |
| Dec 31, 2020 | 8,664.00% |
| Sep 30, 2020 | 2,045.45% |
| Dec 31, 2019 | 6,768.75% |
| Sep 30, 2019 | -12,600.00% |
| Jun 30, 2019 | -266,300.00% |
| Mar 31, 2019 | -1,194.44% |